SCF complexes are E3 ubiquitin-protein ligases that mediate degradation of regulatory and signaling proteins and control G 1 /S cell cycle progression by degradation of G 1 cyclins and the cyclin-dependent kinase inhibitor, Sic1. Interchangeable F-box proteins bind the core SCF components; each recruits a specific subset of substrates for ubiquitylation. The F-box proteins themselves are rapidly turned over by autoubiquitylation, allowing rapid recycling of SCF complexes. Here we report a role for the UbL-UbA protein Ddi1 in the turnover of the F-box protein, Ufo1. Ufo1 is unique among F-box proteins in having a domain comprising multiple ubiquitin-interacting motifs (UIMs) that mediate its turnover. Deleting the UIMs leads to stabilization of Ufo1 and to cell cycle arrest at G 1 /S of cells with long buds resembling skp1 mutants. Cells accumulate substrates of other F-box proteins, indicating that the SCF pathway of substrate ubiquitylation is inhibited. Ufo1 interacts with Ddi1 via its UIMs, and ⌬ddi1 cells arrest when full-length UFO1 is overexpressed. These results imply a role for the UIMs in turnover of SCF Ufo1 complexes that is dependent on Ddi1, a novel activity for an UbL-UbA protein.
Ubiquitin-mediated proteolysis determines protein abundance and is a major pathway for regulating crucial biological processes (14) . Proteins are degraded in the 26S proteasome that consists of a 20S catalytic chamber (CP) and a 19S regulatory particle (RP) (11) . Target proteins are usually marked by phosphorylation, and this links substrate recruitment with intrinsic signal transduction pathways that are activated in response to environmental cues (39) . Substrates targeted for degradation by the 26S proteasome are covalently modified with short ubiquitin chains by a cascade of E1 ubiquitin-activating, E2 ubiquitin-conjugating, and E3 ubiquitin-ligase activities (14) . Substrate ubiquitylation usually occurs in macromolecular complexes, exemplified by the SCF (for Skp1-Cdc53/ Cul1-F-box protein) and the APC (for anaphase promoting complex). These two complexes are the major engines that drive the cell cycle being responsible for degradation of cyclins and the cyclin kinase inhibitor (CKI), Sic1 inter alia (5) . The SCF complex has a major role in G 1 /S progression. It consists of a Cdc53/Cul1 rodlike scaffold whose N terminus serves as a docking site for a substrate recognition module comprising a F-box protein and the Skp1 adaptor. The Cdc53 C-terminal domain forms a heterodimeric catalytic module with the RING protein, Rbx1, and this serves as a landing pad for the E2; in yeast it is Cdc34 (7) . The SCF core elements Cdc53 and Skp1 are stable proteins, whereas F-box proteins are generally shortlived and undergo autoubiquitylation by Cdc34. The canonical assembly of different SCF complexes thus provides a rapid mechanism for regulating cell cycle progression and for checkpoint-mediated response to stalled DNA replication or DNA damage at different points of the cell cycle and in response to changes in the availability of nutrients in the cell environment (9, 46) . The F-box protein Ufo1 was identified during a study on the regulation of the activity of the mating switch endonuclease, Ho (22) . Transcription of UFO1 is induced in response to DNA damage (20) , and deletion of UFO1 has been observed to affect genome stability (40) . Ufo1 is an unusual F-box protein in that besides the F-box and protein-protein interaction domains present in other F-box proteins, it has four copies of the ubiquitin-interacting motif (UIM). The UIM is a short Nterminal acidic box, followed by alternating long and short hydrophobic residues that terminates in an invariant signature sequence A-X-X-X-S (15) . The UIM was originally identified as the ubiquitin chain-binding domain of subunit Rpn10 of the proteasome 19S RP (35) ; however, all other UIM proteins are components of the intracellular vesicular trafficking system (15) . A comprehensive search of the protein databases indicates that it is only Ufo1 and its fungal orthologs that have UIMs. The UIM of the intracellular trafficking protein Epsin promotes ubiquitylation of glutathione S-transferase (GST) in the context of a GST-UIM Epsin fusion protein (34) . Furthermore, during self-ubiquitylation of Hgs1, an adaptor protein that targets the EGF receptor for degradation, the Hgs1 UIM plays an essential role in recruitment of the E3, Nedd4 (25) .
Here we report that deletion of the Ufo1 UIMs creates a dominant-negative phenotype of inactivation of the SCF pathway of protein degradation. The cells arrest with long buds resembling skp1-3 mutants at the restrictive temperature, corresponding to a G 1 /S arrest. Furthermore, we show that there is a specific interaction between Ufo1 and the UbL-UbA protein Ddi1. This interaction requires the presence of the UIMs of Ufo1 and is important for the turnover of SCF Ufo1 complexes and cell cycle progression.
MATERIALS AND METHODS
Strains. W303 (MATa his3 leu2 trp1 ura3-52) and isogenic wild-type and ⌬rad23 ⌬dsk2 ⌬ddi1 mutant strains were purchased from Euroscarf. The wild type and ⌬ufo1 mutant are Research Genetics BY4730 and #142, respectively.
The G 1 /S skp1-3 mutant is described elsewhere (26 Haguenauer-Tsapis. The atg7 mutant was generated by one-step gene replacement in Euroscarf BY4741 by using the primers ATG7-URAF (ATAACTAAA G T T C A T T A TATTTCAACAAATATAAGATAATCAAGAATAAAATGTCGAAAGCTA CATATAAGG) and ATG7-URAR (CCGCAAGTTCTGCCTTTGGCTTTCCAC AGTCCTCAAAATTATATAACGCT TTAGTTTTGCTGGCCGCATCTTC) to introduce URA3 at the genomic ATG7 locus. Cells expressing hemagglutinin (HA)-tagged Cln2 were prepared by integrating plasmid pRD114a from R. Deshaies at the LEU2 locus. SIC1 was deleted in the cdc53 ts strain above by using the primers SicHIS3F (AAATCAATCAACCAAACCTCTACGGAATTTTGACC CTTGAAGCAGGGACTATTACACGAAAATGACAGAGCAGAAAGCCC) and SicHIS3R (ATGTAGAATAAGTAAGTAAATAAAATATAATCGTTCC AGAAACTTTTTTTTTTCATTTCTCTACATAAGAACACCTTTGG) to substitute HIS3 for the genomic SIC1 gene.
Plasmids. Construction of pGAL-GFP-UFO1 is described in reference 21; construction of of pTET-HO-LACZ is described in reference 22. pGFP-UFO1⌬UIM was cloned in plasmid pYCPGAL (41) by using the primers Ufo1BamF (CGGGA TCCATGGAGCGGCCTGGCTTGGTATTGC) and Ufo1SalR (CCGACAGGA TCCCCCGCTTAAGCTTGATTCCG) to amplify genomic UFO1. The K134A K141A mutations were introduced by primer overlap extension by using the external primers described above and the mutagenic primers NLSHindF (CACGCAAGGC AGAAGAAATTTAAAGCTTTGATTTATATTCC) and NLSHindR (GGAAT ATAAATCAAAGCTTTAAATTTCTTCTGCCTTGCGTG). The GFP-UFO1-UIMs was subcloned into the same plasmid by using the primers UfoUIMBamF (GCACTCTTAGGATCCCAGGAGGCGCAAGC) and UfoUIMBamR (GCG GATCCTCAATTGATTTCACTCAATGAC). The genomic UIM domain was replaced with a TAP tag (36) by using the primers Ufo⌬UIMTAPF (CGGAA TCAAGCTGAAGCGGGGGAGCCTGTCGGAGATGATGTCCATGGAAA AGAGAAG) and Ufo⌬UIMTAPR (CTATAAATAAAATATTTAACATATGC TCTTCCAAATGTACATACTTTCATACGACTCACTATAGGG) to amplify the tag from plasmid pBS1479 (Euroscarf). The clone for overexpressing GFP-F-box residues 1 to 233 was made by deleting all residues between the HindIII site at bp 700 of the UFO1 open reading frame and a similar site in the vector. Ufo1 deleted for its F-box was cloned into pOBD using primers WDF (GGAT TCAATATTAATGCTGCAGTG) and UIMR (GATCCCCGGGAATTGCCA TGTCAATTGATTTCACTCAATGACAACGCAAT). The fusion of the Ufo1 WD40 domain in pOAD is described in reference 21.
CLN2 and SIC1 were cloned as GFP fusion proteins in YCPGAL by using the primers YCpGALCLN2BamF (CCATTCATTCATTAAATTTAAGGATCCA CAATGGCTAGTGC) and YCpGALCLN2BamR (GGTACGTTTGGCAAAT TGGGATCCATTTATCATGAAAAGAACAGG) and the primers YCpGALSIC1BamF (CGGAATTTTGACCCTGGATCCAGGGACTATTACACGAAA ATG) and YCpGAL-SIC1BamR (GTAAATAAAATATAATGGATCCAGAA ACTTTTTTTTTTCATTTC), respectively.
Subclones of Ddi1 with the UbL or UbA domain deleted were LexA fusions (3). 2m plasmids with SKP1 from a genomic library, or CDC4 cloned as a PCR product amplified from genomic DNA, were a gift from D. Kornitzer. GST-Ddi1 was a gift of D. Skowyra and GST-Rad23 and GST-Dsk2 were obtained from S. Elsasser (8) .
Yeast two-hybrid system. UFO1 was fused to the Gal4 activation domain of pOAD (4). Rad23, Dsk2, and Ddi1 fusions to the Gal4 DNA-binding domain were from Ito et al. (17) . The plasmids were cotransformed into yeast strain PJ694a, where three reporter genes are under the control of the GAL promoter (19) and cells in which the two proteins interact can grow on selective plates lacking histidine and adenine. Transformations of yeast cells were performed by using lithium acetate (1) .
Protocols for metabolic labeling, immunoprecipitation, and pulse-chase are described in reference 21, as are the methods for coimmunoprecipitation and immunoblotting. In these experiments, GFP-UFO1 was induced from the GAL promoter by overnight growth in minimal medium with 2% galactose. In the experiment with G 1 -arrested cells, overnight cultures were diluted into medium with 2 g of ␣-factor/ml and 2% galactose, followed by incubation for 3 h before promoter shutoff by the addition of 3% glucose. An overnight 50-ml culture of 10 8 cells/ml served as the source of a 300-l extract that had 80 g of protein/l. A total of 190 l (15 mg of protein) was taken for immunoprecipitation (IP) with anti-Ddi1 or anti-GFP, and the immunoprecipitate was run in a single lane for Western blotting (WB) with the appropriate antisera. Anti-Ddi1 was a gift from J. Gerst and was used at dilutions of 1:1,000 for IP and 1:5,000 for WB; anti-GFP antiserum from Roche Molecular Biochemicals and anti-myc (mouse monoclonal antibody 9E10) from Santa Cruz Biotechnology were used at 1:200 for IP and at 1:1,000 for WB. Goat anti-mouse and goat anti-rabbit antibodies were used at 1:1,000 and were from Santa Cruz Biotechnology. Protein A-Sepharose was purchased from Amersham and was used at 50%; 30-l portions were added to each sample.
Microscopy. Cells expressing green fluorescent protein (GFP)-tagged proteins were observed with a Nikon fluorescence microscope fitted with GFP-specific filters (dichromic 505 nm, excitation 450 to 490 nm, emission 515 nm). Images were captured with a Micromax 512 BFT camera (Roper Scientific) by using WinView32 imaging software.
RESULTS
Deletion of the Ufo1 UIMs leads to cell cycle arrest. Ufo1 has an F-box domain (residues 5 to 51) attached via a linker to a WD40 repeat region (residues 190 to 420) that binds substrates for degradation. The unique UIMs are between residues 547 and 668. At least two canonical UIMs are present in most fungal Ufo1 orthologs, with many species, among them Saccharomyces cerevisiae, showing up to four motifs. To determine the functional significance of the UIMs of Ufo1, we expressed from the GAL promoter in wild-type yeast, fulllength pGFP-UFO1, and truncated UFO1 without the UIMs (pGFP-UFO1⌬UIM). pGFP-UFO1 transformants grew normally on galactose plates, whereas those that expressed pGFP-UFO1⌬UIM were growth inhibited. Growth could be restored by ectopic expression of SKP1 (Fig. 1A) . pGFP-UFO1⌬UIM cells in liquid culture arrested with long buds, similar to the G 1 /S arrest phenotype of skp1-3 mutants at 37°C, implying a lack of SCF function ( buds. These experiments relied on high-level expression of UFO1 and its truncated form. We therefore investigated the effect of deleting the UIMs in genomic UFO1. This was done by integrating a PCR product encoding a TAP tag and the TRP1 marker gene (36) either just prior to the stop codon of UFO1 (UFO1 1-668 ::TAP) or in place of its UIMs (UFO1 1-538 uim::TAP). Cells expressing UFO1 ::TAP grew normally, whereas those expressing UFO1 1-538 uim::TAP formed microcolonies with cells arrested with long buds. These cells did not continue to grow, and the transformants died shortly after reaching the stage shown in Fig. 1C . This is in contrast to ⌬ufo1 mutants that have no obvious growth phenotype.
Ufo1⌬UIM is active in Ho degradation. The G 1 /S arrest could be due to lack of degradation of a substrate of Ufo1 that has a role in cell cycle progression. However, we found that the Ufo1 substrate, Ho endonuclease, was degraded with a similar half-life in the presence of full-length Ufo1 or Ufo1⌬UIM, indicating that Ufo1⌬UIM is capable of forming active SCF complexes. This was done by cotransforming ⌬ufo1 cells with pGFP-UFO1 or pGFP-UFO1⌬UIM together with pTET-HO-LACZ and measuring the half-life of Ho-LacZ by pulse-chase and IP ( Fig. 2A) .
Cln2 accumulates in the presence of Ufo1⌬UIM. The lethality caused by deletion of the genomic UFO1 UIMs implies that Ufo1 is exerting a dominant-negative effect on the SCF pathway. If the deletion of the Ufo1 UIMs is interfering directly with SCF Ufo1 turnover, we would expect cells producing Ufo1⌬UIM to accumulate SCF degradation substrates of other F-box proteins such as Cln2 (ubiquitylated by SCF Grr1 ), and the Cdk inhibitor Sic1 (ubiquitylated by SCF Cdc4 ) (38) . Indeed, Western blotting demonstrated significant accumulation of Cln2 in cells expressing pGFP-UFO1⌬UIM but not in cells expressing full-length UFO1 (Fig. 2B) . Furthermore, in an anti-GFP immunoprecipitation and Western blot experiment, we could show directly that the turnover of Cln2 is retarded when GFP-UFO1⌬UIM, but not GFP-UFO1, is expressed (Fig.  2C ). These data are further supported genetically by the observation that the cell cycle arrest upon GFP-UFO1⌬UIM expression was ameliorated in a ⌬sic1 mutant and by the accumulation of Sic1 in these cells (Fig. 2D) .
Suppression of the arrest caused by deletion of the UIMs of Ufo1. The data presented above show that Ufo1⌬UIM has a dominant-negative effect on SCF activity, suggesting that it may sequester core subunits of the SCF. We therefore tested whether the arrest can be suppressed by coexpression of subunits of the SCF. F-box proteins are recruited to the SCF by binding the Skp1 adaptor; however, we showed previously that the Ufo1 F-box domain binds both Skp1 and Cdc53 and that a WD40 domain subclone binds Cdc53 (21) . Thus, Ufo1 may be sequestering both core components of the SCF and preventing them from recycling. In accordance with this we found that overexpression of the F-box protein, CDC4, suppressed the phenotype of cells with a deletion of the genomic UFO1 UIMs, UFO1 1-538 uim::TAP. Presumably, the large amounts of Cdc4 could compete for binding the SCF core subunits, implying that they are indeed limiting for substrate degradation (Fig. 3A  and B) . Similarly, when we coexpressed SKP1 with UFO1⌬UIM we found marked restoration of growth with only 16% arrested cells with long buds. Likewise, coexpression of CDC53 suppressed the cell cycle arrest induced by UFO⌬UIM by half. The Ufo1 WD40 domain alone fused to the Gal4 DNA activating domain did not cause cell cycle arrest, and high-level expression of an Ufo1 F-box clone and putative linker region (residues 1 to 233) led to only 13% arrested cells compared to ca. 50% when Ufo1⌬UIM was produced from the same plasmid ( Fig. 3A and B) . A mutant version of Ufo1⌬UIM in which we introduced two point mutations into a putative nuclear local- ization sequence of basic residues between the F-box and the WD40 domains, Ufo1⌬UIM K134A,K141A , was not affected in nuclear import of Ufo1 but did lead to suppression of the cell cycle arrest induced by Ufo1⌬UIM (Fig. 3C) . Taken together, the results confirm that it is the truncated Ufo1⌬UIM protein itself that is directly inhibiting cell cycle progression and that contacts between the Ufo1 F-box domain and both Skp1 and Cdc53 are involved in the dominant-negative effect on function of other SCF complexes. Moreover, this experiment emphasizes the difference between the inhibitory effect on the cell cycle of Ufo1⌬UIM, which consists of the F-box and WD40 domains, compared to the rescue by Cdc4 comprising the same two domains.
Ufo1 is a long-lived F-box protein, and its degradation requires SCF activity. Most F-box proteins are short-lived and undergo autoubiquitylation by the SCF and degradation by the proteasome (43) . Ufo1 has an unusually long half-life in a pulse-chase and IP experiment with Ͼ50% still present after 1 h (Fig. 4A) . We confirmed the role of the proteasome in Ufo1 degradation by comparing the half-life of Ufo1 in the presence or the absence of the proteasome inhibitor, MG132 (27) . The rate of Ufo1 turnover is severely retarded in the presence of MG132 (Fig. 4B) . Moreover, Ufo1 degradation shows a requirement for a functional SCF Ufo1 complex: Ufo1 deleted of its FB domain, which cannot be incorporated into SCF complexes, is not degraded in wild-type cells (Fig. 5A) . Likewise, Ufo1 degradation is severely retarded in both cdc34 and cdc53 mutants at the restrictive temperature (Fig. 5B) . Both cdc34 and cdc53 mutants arrest at the G 1 /S interphase at 37°C; however, Ufo1 was degraded normally in ␣-factor-arrested G 1 cells, excluding the possibility that Ufo1 degradation requires progression into S phase. Furthermore, Ufo1 was stabilized in cdc53 mutants in which SIC1 was deleted to enable cell cycle progression (Fig. 5C ). These results indicate that the main pathway for ubiquitylation of Ufo1 involves SCF Ufo1 , followed by degradation in the proteasome.
These experiments show some degradation of Ufo1 in cdc34 and cdc53 mutants, and we tried to identify functions of an additional degradation pathway. Given the presence of the UIMs in proteins involved in intracellular trafficking and the finding that mammalian Hgs1 is ubiquitylated by the E3 Nedd4 (yeast Rsp5), we tested whether this may involve Rsp5 and the vacuole. We did not find a requirement for Rsp5 for degradation of Ufo1 and also no requirement for the autophagy pathway which is inhibited in atg7 mutants (33) (Fig. 5D) . Nor was Ufo1 stabilized by phenylmethylsulfonyl fluoride, an inhibitor of certain lysosomal proteases (24) (Fig. 5E) .
The Ufo1 UIMs are required for degradation of Ufo1. The experiments described above suggest that the cell cycle arrest may be due to the Ufo1⌬UIM protein sequestering the endogenous Skp1-Cdc53 subunits of the SCF and acting as a dominant negative, preventing assembly of other SCF complexes. In this model, the UIMs of Ufo1 are critical for its degradation. To explore directly whether Ufo1 degradation is dependent on its UIMs, we collected aliquots of cells overexpressing pGAL-GFP-UFO1 and pGAL-GFP-UFO1⌬UIM over a 3-h period after transfer from galactose to glucose medium to obtain promoter shutoff. Ufo1 was present at the 1-h time point but had disappeared by 2 h. In contrast, Ufo1⌬UIM was markedly stabilized and could still be found at the 3 h time point. Thus, in the absence of its UIMs, the half-life of Ufo1 is extended, and this could explain inactivation of SCF function when it is overexpressed; it could also explain the lethality induced by deletion of the genomic UFO1 UIMs. Ufo1⌬UIM K134A,K141A in which the cell cycle arrest is suppressed, has a half-life comparable to that of Ufo1, further strengthening the correlation between extended half-life and cell cycle arrest (Fig.  6A) . The UbL-UbA protein, Ddi1, is required for Ufo1 turnover. Our results indicate that truncation of the Ufo1 UIMs did not affect the ability of Ufo1⌬UIM to form active SCF complexes as evidenced by normal degradation of Ho endonuclease (Fig.  2) . However, Ufo1⌬UIM had a considerably extended half-life (Fig. 6A) . Therefore, deletion of the Ufo1 UIMs may be interfering with a function downstream of ubiquitylation. We recently found that the ubiquitin domain protein Ddi1 is required for the final stages of degradation of Ho and that, in the absence of Ddi1, Ho accumulates in a stable ubiquitylated form (23) . Ddi1 belongs to a family of UbL-UbA proteins proposed to act as proteasome receptors for ubiquitylated substrates (11, 35) . We therefore tested whether any of the UbLUbA proteins-Rad23, Dsk2, or Ddi1-is required for Ufo1 degradation. We induced pGFP-UFO1 in galactose medium overnight in rad23, dsk2, and ddi1 deletion mutants and collected aliquots of cells at 30-min intervals after transfer to glucose for promoter shutoff. Ufo1 is highly stabilized in ⌬ddi1 mutants, whereas it was degraded with a half-life similar to that observed in wild-type cells in rad23 and dsk2 mutants (Fig. 6B) . These results imply that Ddi1 has a role in Ufo1 degradation and thus in the turnover of SCF Ufo1 complexes. Ufo1 binds Ddi1 in two-hybrid and co-IP experiments. In accordance with this, when we tested for complex formation between Ufo1 and the UbL-UbA proteins Ddi1, Rad23, and Dsk2, we found that Ufo1 interacts only with Ddi1 and not with either Rad23 or Dsk2 in the two-hybrid protein interaction trap (Fig. 7A) . Deletion of the UIMs of Ufo1 abrogated its interaction with Ddi1 in a co-IP experiment (Fig. 7B ). An analysis of the domains of Ddi1 involved in interaction with Ufo1 showed that deletion of the UbL of Ddi1 abrogated binding to Ufo1 and that deletion of the UbA of Ddi1 reduced the interaction considerably (Fig. 7C) . These results suggest that Ddi1 may have a role in the turnover of Ufo1 and, by implication, of SCF Ufo1 complexes. This leads to the prediction that expressing full-length GFP-UFO1 in ⌬ddi1 cells would phenocopy expression of GFP-UFO1⌬UIM in DDI1 cells. Indeed, we found that, whereas full-length UFO1 overexpression in wild-type cells did not affect cell cycle progression and it was only truncation of the Ufo1 UIM that led to arrest, in ⌬ddi1 cells a very similar level of cell cycle arrest was obtained irrespective of the presence or absence of the Ufo1 UIMs (Fig.  7D ). Ddi1 itself is very stable, with little sign of degradation over 3 h; its turnover was not affected by deletion of Ufo1 (Fig.  7E) .
The role of the Ufo1 UIMs in binding Ddi1 was pursued further in a series of pull-down experiments: a yeast subclone comprising the Ufo1 UIMs fused to GFP was found to interact with all three UbL-UbA proteins-Ddi1, Rad23, and Dsk2-made as GST fusion proteins in bacteria (Fig. 8A) . However, when full-length Ufo1 was tested under the same conditions, it bound solely to Ddi1 (Fig. 8B) . When increasing amounts of GFP UIMs were added to a reaction comprising GST Ddi1 on beads and yeast lysate with GFP Ufo1, the presence of the UIMs inhibited complex formation between Ufo1 and Ddi1 in a dose-dependent manner (Fig. 8C) .
DISCUSSION
Our results demonstrate that the turnover of the F-box protein, Ufo1, is essential for proper functioning of the SCF ubiquitylation pathway. SCF activity appears to be finely tuned, and malfunction in turnover of a subset of SCF complexes rapidly leads to cell cycle arrest. Most F-box proteins are inherently unstable (43) ; in the case of Ufo1, its unique UIMs are the determinants for its degradation and for SCF Ufo1 turnover. The marked effect on SCF activity when Ufo1⌬UIM is overexpressed and even moreso when the UIMs of the genomic UFO1 gene are deleted is an indication that the levels of the core SCF components are stringently regulated and that there is not a large pool of free subunits. Skp1 participates in different complexes, the centromeric complex (6) , and in a complex with the Golgi complex-related F-box protein, Rcy1 (10) , that do not involve Cdc53. Our data imply that its partitioning must be very tightly regulated since it is not rapidly mobilized from either of these complexes. Transformants in which the UIMs of genomic UFO1 are deleted reach the stage of microcolonies and then die, whereas after about 20 h in liquid culture, cells expressing ectopic UFO1⌬UIM resume growth, and this could be due to upregulation of biosynthesis of the core SCF elements.
To date, research on substrate degradation by the proteasome has focused on how substrates are marked for recruitment by F-box proteins. An extreme case is the CKI, Sic1, that requires a minimum of six phosphorylations to form a stable complex with Cdc4. The actual residues phosphorylated are less important than their total number, and this is interpreted to be a mechanism that links nutritional availability with entry into the cell cycle (32) . The underlying assumption is that once a stable complex between phosphorylated Sic1 and Cdc4 is formed, substrate degradation followed by SCF turnover are assured. In contrast, we find that extraction of Ufo1 from SCF Ufo1 complexes is a highly regulated process and depends specifically on its unique UIMs.
The SCF alternates between an active and inactive state regulated by neddylation of Cdc53 (43) . In Schizosaccharomyces pombe and higher eukaryotes the signalosome (CSN) is responsible for inactivating SCF function by deneddylation. In conditions when SCF activity is limiting, the deneddylation by the CSN and the deubiquitylating activity of its associated DUB are critical for survival. This is due to their stabilization of the F-box protein, which would otherwise be rapidly eliminated in an autocatalytic reaction on binding active SCF core elements (42) . Our experiments show that Ufo1 degradation requires the SCF functions Cdc53 and its associated E2, Cdc34. Stabilization of Ufo1 deleted for its F-box domain indicates the importance of incorporation of Ufo1 into SCF complexes for its degradation. Deletion of the Ufo1 UIMs leads to extension of the half-life of Ufo1. Ufo1⌬UIM resembles canonical F-box proteins that do not have UIMs, and its extended half-life may perhaps be attributed to the UIMs superseding internal degron sequences similar to those identified in Cdc4 and Met30 (9, 31, 46) . The S. pombe ortholog of Ufo1, Pof10, is also very stable, and in this species overexpression of the full-length protein leads to loss of viability (16) . The finding that Ufo1⌬UIM K134A,K141A does not lead to cell cycle arrest despite the absence of UIMs suggests that interactions of Ufo1⌬UIM with other protein(s) are important. These mutations are in the vicinity of the F-box domain and may affect the strength of binding between the Ufo1 F-box domain and Skp1 and/or result in a different positioning of Ufo1⌬UIM K134A,K141A within the SCF Ufo1 complex. For example, in S. pombe a defined point mutation in the F-box binding region of Skp1 differentially affects its binding affinity for different F-box proteins (28) . Alternatively, F-box proteins may have a unique pathway of degradation: the proteasome receptor, Cic1, that binds an ␣ subunit of the 20S CP mediates degradation of the F-box proteins Cdc4 and Grr1. Cic1 is not required for degradation of Ufo1 (not shown); however, the existence of a different 20S CP-interacting proteasome receptor cannot be excluded (18) . Mutant Ufo1⌬UIM K134A,K141A may be treated as an SCF ubiquitylated substrate rather than as a component of the SCF complex and may be degraded via a different postubiquitylation pathway.
There is growing evidence for regulation of additional stages in the assembly of active SCF complexes. Entry of Skp1 into SCF complexes is inhibited by Cadmium: in the presence of Cadmium the F-box protein, Met30, binds its substrate Met4 but no longer binds Skp1 (2, 44) . A further downstream regulated interaction is demonstrated between the Skp1-like BTB-adaptor, Keap1, that binds its substrate, the transcription factor Nrf2, but no longer binds the Cul3 scaffold under stress conditions. This abrogates ubiquitylation of Nrf2 and leads to its stabilization (45) . These experiments show that in addition to F-box protein recruitment of a substrate that is marked for degradation by signal transduction pathways, assembly of the substrate-F-box protein complex into active SCF complexes is a highly regulated process. The interaction of Ufo1 with Ddi1 is important for the degradation of Ufo1 and for the turnover of SCF Ufo1 complexes. This may be by recycling the SCF core components Skp1 and Cdc53 into alternative SCF complexes. Ddi1 is a very stable protein and is not a degradation substrate of Ufo1. The Ufo1 UIMs bind all yeast UbL-UbA proteins indiscriminately; however, full-length Ufo1 only binds Ddi1. The UIMs are required for its interaction with Ddi1. The importance of the interaction between Ufo1 and Ddi1 is shown most clearly by the extended half-life of Ufo1 in ⌬ddi1 mutants and by the cell cycle arrest of ⌬ddi1 cells induced by overexpression of fulllength UFO1. These genetic data are supported by experimental data obtained with the two-hybrid system and in co-IP experiments that demonstrate that both the UbL and UbA domains of Ddi1 are required for interaction with Ufo1. Regulation of the SCF pathway is a novel function for an UbLUbA protein. The UbL domain of Ddi1 is required for interaction with the 19S RP of the proteasome, and one model for activation of an UbL-UbA protein could be that binding of a K48-linked ubiquitin chain to the UbA domain frees the UbL domain to bind the proteasome. This model is suggested by our finding that Ddi1 can bind ubiquitylated Ho in the absence of its UbL domain (23) . Furthermore, the UbL of Rad23 interacts with its UbA domain, and this may represent an inactive form of the protein (37) . The UbA domain of Ddi1 is a cisstabilization element (13) , and we have shown that it interacts with ubiquitin-conjugated Ho (23) . Here, too, we find that it is important for the interaction of Ddi1 with Ufo1. Furthermore, it has been shown that the UbL-UbA KPC2 subunit is required to stabilize the KPC1 RING subunit of the heterodimeric E3 (12) . This mechanism regulates function of the E3 for p27, a cyclin-dependent kinase inhibitor in mammalian cells. It will be interesting to decipher how these competing interactions for the Ddi1 UbL are regulated. Our experiments identify further regulatory steps that determine whether the ubiquitylated substrate will be processed further by functions of the pathway that leads to its degradation. In addition, Ddi1, alias Vsm1, has a role in intracellular membrane transport (29, 30) , and it is not clear whether this role involves its association with Ufo1. We propose a model in which Ufo1 and Ufo1⌬UIM are incorporated into SCF complexes and can support substrate ubiquitylation, but after that their fates differ. Interaction between the Ufo1 UIMs and the UbL of Ddi1 could be required for activation of Ddi1 for destabilization of the SCF Ufo1 complex. In this model the UbL and UbA domains would play a regulatory role and gate access to the Ddi1 core. (In this scenario one possible explanation for the marked reduction [ca. 90%] in the binding of Ufo1 to Ddi1 lacking its UbA domain may reflect a similar lack of accessibility to the Ddi1 core.) The interaction between the Ufo1 UIMs and Ddi1 is not required for substrate extraction but is specifically required for turnover of SCF Ufo1 complexes. This may involve repositioning of Ufo1 by Ddi1 within the SCF complex so that it now becomes accessible to the E2 and/or on the proteasome so that it can be deubiquitylated, unfolded, and degraded. In the absence of the Ufo1 UIMs or of Ddi1 the half-life of Ufo1 is extended, and this leads to inhibition of the SCF pathway of substrate degradation (Fig. 9) . FIG. 9 . Model for interaction between Ufo1 and Ddi1. Ufo1 and Ufo1⌬UIM are shown in a complex with Skp1 (S) and Cdc53 (53) via contacts of both their F-box (F) and WD40 domains. (R is Rbx1). Interaction between the Ufo1 UIMs and the UbL domain of Ddi1 promotes degradation of Ufo1 and recycling of SCF Ufo1 complexes. The interaction between Ddi1 and Ufo1 also involves its UbA domain that may need to be released from interaction with the UbL domain to make contact with the ubiquitin chains on Ufo1. 
